Regulatory News for November 2013

The British Government and pharmaceutical companies have agreed a new five-year, multi-billion pricing deal that will introduce a fixed limit on NHS spend on branded medicines The British Government and pharmaceutical companies have agreed a new five-year, multi-billion pricing deal that will introduce a fixed limit on NHS spend on branded medicines

The British Government and pharmaceutical companies have agreed a new five-year, multi-billion pricing deal that will introduce a fixed limit on NHS spend on branded medicines for the first time ever with all additional expenditure above this level paid for by industry.
07 November, 2013